全文获取类型
收费全文 | 979篇 |
免费 | 37篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 8篇 |
妇产科学 | 2篇 |
基础医学 | 141篇 |
口腔科学 | 25篇 |
临床医学 | 71篇 |
内科学 | 197篇 |
皮肤病学 | 5篇 |
神经病学 | 39篇 |
特种医学 | 6篇 |
外科学 | 250篇 |
综合类 | 4篇 |
预防医学 | 25篇 |
眼科学 | 16篇 |
药学 | 49篇 |
肿瘤学 | 191篇 |
出版年
2023年 | 7篇 |
2021年 | 7篇 |
2020年 | 6篇 |
2019年 | 5篇 |
2016年 | 9篇 |
2015年 | 9篇 |
2014年 | 15篇 |
2013年 | 14篇 |
2012年 | 26篇 |
2011年 | 37篇 |
2010年 | 30篇 |
2009年 | 24篇 |
2008年 | 56篇 |
2007年 | 56篇 |
2006年 | 52篇 |
2005年 | 68篇 |
2004年 | 42篇 |
2003年 | 48篇 |
2002年 | 60篇 |
2001年 | 29篇 |
2000年 | 26篇 |
1999年 | 20篇 |
1998年 | 22篇 |
1997年 | 15篇 |
1996年 | 30篇 |
1995年 | 21篇 |
1994年 | 24篇 |
1993年 | 19篇 |
1992年 | 26篇 |
1991年 | 27篇 |
1990年 | 22篇 |
1989年 | 17篇 |
1988年 | 12篇 |
1987年 | 19篇 |
1986年 | 13篇 |
1985年 | 10篇 |
1984年 | 5篇 |
1983年 | 8篇 |
1979年 | 12篇 |
1978年 | 8篇 |
1977年 | 7篇 |
1976年 | 4篇 |
1973年 | 4篇 |
1972年 | 5篇 |
1970年 | 7篇 |
1969年 | 7篇 |
1968年 | 3篇 |
1967年 | 7篇 |
1966年 | 5篇 |
1965年 | 4篇 |
排序方式: 共有1030条查询结果,搜索用时 15 毫秒
21.
M Wakakura K Mashimo S Oono Y Matsui A Tabuchi K Kani K Shikishima K Kawai Y Nakao Y Tazawa M Kiyosawa H Abe N Ohba K Yago S Maeda M Sugita S Ishikawa 《Japanese journal of ophthalmology》1999,43(2):133-138
BACKGROUND: A randomized, controlled clinical trial was conducted in 1991 to compare an intravenous megadose of methylprednisolone with a control drug (mecobalamin) for treating acute idiopathic optic neuritis. CASES: Sixty-six cases from 22 clinical centers throughout Japan were examined to evaluate the treatment on visual function parameters, such as visual acuity, visual field, color vision, contrast sensitivity, and critical flicker frequency. OBSERVATIONS: The methylprednisolone pulse treatment group showed faster recovery of visual function, particularly the visual acuity at 1 week (P<.05), Humphrey field analyzer mean deviation at 3 weeks (P<.05), and color vision at 1 week (P<.05). Recovery of contrast sensitivity at several different spatial frequencies was significant in the pulse treatment group at 1 (P<.01), 2 (P<.05), and 4 weeks (P<.05) after the start of treatment. Visual function test results at 12 weeks and 1 year were essentially the same in the two treatment groups. Side effects appeared more frequently in the pulse treatment group than in the control (P<.05). CONCLUSIONS: Pulse treatment does not appear effective for idiopathic optic neuritis even though visual function in the pulse treatment group of this trial recovered more quickly during the initial phase compared to the controls. More effective and specific treatment should be established for optic neuritis. 相似文献
22.
Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: relationship to e-cadherin expression. 总被引:5,自引:0,他引:5
Takeshi Shimamura Michiie Sakamoto Yoshinori Ino Yasuto Sato Kazuaki Shimada Tomoo Kosuge Hisahiko Sekihara Setsuo Hirohashi 《Journal of clinical oncology》2003,21(4):659-667
PURPOSE: The E-cadherin-mediated cell adhesion system is frequently inactivated by multiple mechanisms and is involved in tumor progression in many types of cancer. Recently, we reported the cloning and characterization of dysadherin and showed that it downregulated E-cadherin and promoted metastasis. The aim of this study was to investigate the clinical significance of dysadherin expression and the relationship between dysadherin expression and E-cadherin expression in pancreatic ductal adenocarcinoma. PATIENTS AND METHODS: We examined dysadherin and E-cadherin expression in 125 surgically resected pancreatic ductal adenocarcinoma patients using immunohistochemistry. RESULTS: Dysadherin was expressed at the cell membrane of cancer cells, but not in nontumor duct and acinar cells. Its expression was stronger in infiltrative and poorly differentiated nests compared with well-differentiated nests. Although the correlation between the expression of dysadherin and E-cadherin was not significant, a group of patients showed reduced E-cadherin expression with dysadherin overexpression. Increased dysadherin expression was significantly correlated with distant metastasis (P =.047), high tumor grade (P =.006), positive tumor margins (P =.024), and infiltrative type of growth pattern (P =.014). A survival advantage was observed in patients with 0% to 20% dysadherin-positive cells compared with patients with 51% to 100% dysadherin-positive cells, independent of tumor-node-metastasis classification, and World Health Organization tumor grade (P =.019). A combination of increased dysadherin expression and reduced E-cadherin expression (< 90%) further worsened the prognosis. CONCLUSION: In pancreatic ductal adenocarcinoma, dysadherin expression seems to reflect tumor aggressiveness and to be a positive marker of poor prognosis when considered both alone and in combination with downregulation of E-cadherin. 相似文献
23.
Hitoshi Tsuda Chinami Sakamaki Shoichiro Tsugane Takashi Fukutomi Setsuo Hirohashi 《Breast cancer research and treatment》1998,48(1):21-32
In 150 surgically resected primary breast carcinomas that had axillary lymph-node metastases, we examined the incidence of loss of heterozygosity on chromosomes 16p, 16q, 17p, 17q, and 18q, point mutation of the p53 tumor-suppressor gene, nuclear immunoreaction of p53 protein, and amplifications of the c-erbB-2 and int-2 oncogenes by Southern blotting, single-strand conformation polymorphism analysis, and immunohistochemistry. We analyzed the association of these factors and conventional prognostic parameters with outcome of the patients, using Cox's univariate and multivariate analyses. The univariate analysis revealed that nuclear p53 immunoreaction, p53 mutation, and c-erbB-2 amplification as well as the number of metastatic lymph nodes, histological grade, and hormone-receptor statuses were significant prognostic indicators for both recurrence and cancer death. p53 immunoreaction was correlated more strongly with a poor prognosis than p53 mutations. The combination of p53 and c-erbB-2 effectively identified the high-risk patient group, and even among Grade 3 cases the subgroup with these alterations tended to have poorer clinical outcomes. The multivariate analysis including p53, c-erbB-2, and conventional factors. Lymph node status, grade, and p53 had independent impacts on the survival of patients. Under identical adjuvant systemic therapies, prognoses differed between the patient groups with and without alterations of p53 or c-erbB-2. Appropriate combinations of conventional factors with nuclear p53 immunoreaction and c-erbB-2 amplification would help to identify highly aggressive node-positive breast carcinomas and would aid stratification of patient groups in randomized clinical trials of adjuvant systemic therapies. 相似文献
24.
Ohnishi Y Takauchi Y Kamei M Matumura Y Uchida O Kuro M Hayashi Y Mashimo T 《Masui. The Japanese journal of anesthesiology》2000,49(5):523-529
We experienced intraoperative anesthetic management of two cases of heart transplantation in Japan. Both patients were in the end stage of cardiac failure due to dilated cardiomyopathy. One patient had had implantation of left ventricular assist system, and another patient had had implantation of automated cardioveter defibrillator. Transesophageal echocardiography was useful for the monitoring of cardiac function during the operation. Anti-arrythmic therapy including heart pacing and protection of right heart failure are important for the circulatory management of heart transplantation. The anesthesiologist is needed not only for the management of respiration and circulation but also for the prevention of infection and control of the time schedule. 相似文献
25.
Setsuo Takeda Jun-ichi Yamashita Hitoshi Saito Junji Uchida Hiroyasu Satake Yuji Yamada Norio Unemi Yusuke Wataya Hikoya Hayatsu 《Cancer chemotherapy and pharmacology》1991,29(2):122-126
Summary 1-(3-O-Benzyl-2-deoxy--d-ribofuranosyl)-5-trifluoromethyl-2,4(1H,3H)-pyrimidinedione (FTC-092), a fluorinated pyrimidine derivative, appeared to be effective against various transplantable tumors in mice following oral administration, and its activity was superior to that of several other antitumor fluorinated pyrimidines. The ED50 value for FTC-092 the dose effective in achieving 50% inhibition of tumor growth against the solid form of sarcoma 180 was 13.3 mg/kg daily, whereas those for 5-trifluoromethyl-2-deoxyuridine (CF3dUrd), the parent compound of FTC-092, for 1-(2-tetrahydrofuryl)-5-fluorouracil (Tegafur, FT), the prodrug of 5-fluorouracil (FUra), and for FUra were 64.1, 122, and 28 mg/kg daily, respectively. The therapeutic indices (LD10/ED50) of FTC-092, CF3dUrd, FT, and FUra were 4.39, 1.7, 1.35, and 1.65, respectively. FTC-092 itself is not an active agent. After it has been absorbed from the gastrointestinal tract, FTC-092 undergoes a gradual biotransformation, mainly via the action of liver microsomes, releasing CF3dUrd over a long period. The levels of CF3dUrd in the stomach and small intestine of mice after the oral administration of FTC-092 were undetectable, whereas those following the administration of CF3dUrd at the same dose were high for a period of several hours. In contrast, the CF3dUrd level generated in plasma after the administration of FTC-092 remained at a high level for a longer period than did that observed on the administration of CF3dUrd. The low levels of CF3Urd measured in stomach and small-intestine tissues and the maintenance of CF3dUrd in blood over long periods after the administration of FTC-092 are features that favor the possible clinical application of FTC-092.Abbreviations used FTC-092
1-(3-O-benzyl-2-deoxy--d-ribofuranosyl)-5-trifluoromethyl-2,4(1H,3H)-pyrimidinedione
- CF3dUrd
5-trifluoromethyl-2-deoxynridine
- FT
1-(2-tetrahydrofuryl)-5-fluorouracil
- FUra
5-fluorouracil
- F3Thy
5-trifluorothymine
- ILS
increase in life span 相似文献
26.
Kokichi Sugano Hisanao Ohkura Takashi Maruyama Masahiko Watanabe Setsuo Hirohashi Yukio Shimosato Susumu Kodaira Osahiko Abe 《Cancer science》1988,79(5):618-625
Sandwich radioimmunometric assay (RIA) for a new tumor-associated carbohydrate antigen defined by a monoclonal antibody (MoAb), NCC-ST-439, was developed and the antigen levels were determined in sera of normal donors, and patients with various malignant and non-malignant disorders. In normal donors, 97.0% (226/233) of sera were antigen-negative (less than 12 units/ml) except for 7 serum samples from young females. In patients with malignant disorders, 34.2% (82/240) were antigen-positive, in particular 64.0% (16/25) of patients with pancreatic carcinoma, 66.7% (16/24) of patients with recurrent colorectal carcinoma and 54,5% (6/11) of patients with recurrent breast carcinoma. In patients with non-malignant disorders, 6.0% (7/116) were antigen-positive. The positive rate in benign hepatobiliary disorders, including gallstones, hepatitis and liver cirrhosis, was especially low at 4.3% (1/23). We concluded that determination of serum NCC-ST-439 antigen would be useful in serodiagnosis of carcinoma patients. 相似文献
27.
Yoshihiro Matsuno Setsuo Hirohashi Shuichiroh Furuya Michiie Sakamoto Kiyoshi Mukai Yukio Shimosato 《Cancer science》1990,81(11):1137-1140
Surgically resected small hepatocellular carcinomas showing "nodule-in-nodule'formation were analyzed in terms of cell proliferative activity. The analysis was achieved by successful immunohistochemical demonstration of proliferating cell nuclear antigen in formalin-fixed paraffin-embedded tissue sections. Eight nodules (up to 3 cm in diameter) examined were either atypical adenomatous hyperplasia or hepatocellular carcinoma of low histologic grade, containing a discrete inner nodular area composed of obvious hepatocellular carcinoma of higher histologic grade. In all cases, the proliferating cell nuclear antigen labeling index of the latter area was much higher than that of the former, which in turn was slightly higher than that of the non-cancerous liver of the patient in 6 cases. The data presented here provide supporting evidence that the successive emergence and expansion of a more rapidly proliferating subclone within a nodule result in the stepwise progression of malignancy of human hepatocellular carcinoma. 相似文献
28.
29.
Elizabeth A. Maher Isaac Marin‐Valencia Robert M. Bachoo Tomoyuki Mashimo Jack Raisanen Kimmo J. Hatanpaa Ashish Jindal F. Mark Jeffrey Changho Choi Christopher Madden Dana Mathews Juan M. Pascual Bruce E. Mickey Craig R. Malloy Ralph J. DeBerardinis 《NMR in biomedicine》2012,25(11):1234-1244
Glioblastomas and brain metastases demonstrate avid uptake of 2‐[18F]fluoro‐2‐deoxyglucose by positron emission tomography and display perturbations of intracellular metabolite pools by 1H MRS. These observations suggest that metabolic reprogramming contributes to brain tumor growth in vivo. The Warburg effect, excess metabolism of glucose to lactate in the presence of oxygen, is a hallmark of cancer cells in culture. 2‐[18F]Fluoro‐2‐deoxyglucose‐positive tumors are assumed to metabolize glucose in a similar manner, with high rates of lactate formation relative to mitochondrial glucose oxidation, but few studies have specifically examined the metabolic fates of glucose in vivo. In particular, the capacity of human brain cancers to oxidize glucose in the tricarboxylic acid cycle is unknown. Here, we studied the metabolism of human brain tumors in situ. [U‐13 C]Glucose (uniformly labeled glucose, i.e. d ‐glucose labeled with 13 C in all six carbons) was infused during surgical resection, and tumor samples were subsequently subjected to 13C NMR spectroscopy. The analysis of tumor metabolites revealed lactate production, as expected. We also determined that pyruvate dehydrogenase, turnover of the tricarboxylic acid cycle, anaplerosis and de novo glutamine and glycine synthesis contributed significantly to the ultimate disposition of glucose carbon. Surprisingly, less than 50% of the acetyl‐coenzyme A pool was derived from blood‐borne glucose, suggesting that additional substrates contribute to tumor bioenergetics. This study illustrates a convenient approach that capitalizes on the high information content of 13C NMR spectroscopy and enables the analysis of intermediary metabolism in diverse cancers growing in their native microenvironment. Copyright © 2012 John Wiley & Sons, Ltd. 相似文献
30.
Hyoe Inomata Takehiro Watanabe Yoko Iizuka Yi-Qiang Liang Tomoji Mashimo Toru Nabika Katsumi Ikeda Kazuyuki Yanai Takanari Gotoda Yukio Yamori Mitsuaki Isobe Norihiro Kato 《Hypertension research》2005,28(3):273-281
Cardiac hypertrophy and left ventricular hypertrophy are known to be substantially controlled by genetic factors. As an experimental model, we undertook genome-wide screens for cardiac mass in F2 populations bred from the stroke-prone spontaneously hypertensive rats (SHRSP) and normal spontaneously hypertensive rats (SHR) and Wistar Kyoto rats (WKY) of a Japanese colony. Two F2 cohorts were independently produced: F2(SHRSP x WKY) (110 male and 110 female rats) and F2(SHR x WKY) (151 male rats). The ratio of heart weight to body weight (Hw/Bw) was evaluated at 12 months of age in F2(SHRSP x WKY) after salt-loading for 7 months, and at around 15 weeks of age in F2(SHR x WKY) who had been fed a normal rat chow diet. Subsequent to an initial screen with 251 markers in F2(SHRSP x WKY) male progeny, 170 and 161 markers were selected and characterized in F2(SHRSP x WKY) female progeny and F2(SHR x WKY) male progeny, respectively. Markers from four chromosomal regions showed suggestive or significant linkage to Hw/Bw. The strongest and the most consistent linkage was found in the vicinity of D3Mgh16 on rat chromosome (RNO) 3 (a maximal log of the odds score reached 4.0 to 6.6 across the F2 populations studied). In the other three regions on RNO6, RNO10 and RNO13, the degree of linkage was more prominent in either males or females. These data provide solid evidence for a "principal" RNO3 quantitative trait loci regulating Hw/Bw in SHRSP and SHR, and also suggest the possible presence of sexual dimorphism in regard to genetic susceptibility for cardiac hypertrophy. 相似文献